High lead-related complication rate with MicroPort Vega active fixation pacing leads

Europace. 2024 Oct 3;26(10):euae242. doi: 10.1093/europace/euae242.

Authors

Tardu Özkartal¹, Marco Bergonti¹, Maria Luce Caputo^{1

2}, Jacopo Costantino³, Catherine Klersy⁴, Giulio Conte^{1

2}

Affiliations

¹ Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano, Switzerland.
² Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
³ Clinical, Anestesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
⁴ Unit Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

No abstract available

Keywords: Biotronik; Boston Scientific; Complication; Lead; MicroPort; Pacemaker.

MeSH terms

Aged
Aged, 80 and over
Cardiac Pacing, Artificial / adverse effects
Electrodes, Implanted / adverse effects
Equipment Design
Equipment Failure
Female
Humans
Male
Middle Aged
Pacemaker, Artificial* / adverse effects